CA Patent

CA2773003A1 — Orally disintegrating pharmaceutical dosage form containing aripiprazole

Assigned to Ratiopharm GmbH · Expires 2011-03-24 · 15y expired

What this patent protects

The present invention relates to an orally disintegrating dosage form containing aripiprazole. The formulation of the invention shows a fast disintegration.

USPTO Abstract

The present invention relates to an orally disintegrating dosage form containing aripiprazole. The formulation of the invention shows a fast disintegration.

Drugs covered by this patent

Patent Metadata

Patent number
CA2773003A1
Jurisdiction
CA
Classification
—
Expires
2011-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Ratiopharm GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.